Comparison of Sedation Depth Using Dexmedetomidine and Propofol During Spinal Anaesthesia

Correlation of sedation depth assessed by the ramsay sedation scale and bispectral index using intravenous dexmedetomidine or propofol in patients undergoing spinal anaesthesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093144

Enrollment

Registered

2025-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: INJECTION DEXMEDETOMIDINE IV: Dexmedetomidine group (Group D) received an intravenous (IV) initial loading dose of dexmedetomidine at 0.5 ?g/kg over 10 min followed by a maintenance inf

Eligibility

Inclusion criteria

Inclusion criteria: Age Group 18 years to 50 years ASA I and II

Exclusion criteria

Exclusion criteria: Patient refusal Patient with local infections of back and spine Patient having vertebral column anomalies Patient with bleeding disorders Patient with obstructive sleep apnea Patient having hypertension morbid obesity severe hepatic renal endocrinal(DM) neurological disorders Psychiatric drug history gastrointestinal and cardiac dysfunction. History of allergy to drug understudy Patient with ACE inhibitors alpha 2 adrenergic receptors antagonists beta blockers calcium channel blockers

Design outcomes

Primary

Measure	Time frame
Correlation of sedation depth achieved by both IV drugsTimepoint: Till 90 mins	—

Secondary

Measure	Time frame
Hemodynamic Stability Adverse effect if anyTimepoint: Till 90 mins	—

Countries

India

Contacts

Public ContactAshish Bhatiya

Government Medical College Baroda

dr.mantujr@gmail.com9879541238

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026